期刊文献+

甘精胰岛素和预混胰岛素联合降糖药改善老年糖尿病患者血糖指标及生活质量影响探究 被引量:2

Effectiveness of Insulin glargine and premixed insulin combined with hypo-glycemic in improving glycemic levels and life quality of old patients with diatetes
下载PDF
导出
摘要 目的探讨老年糖尿病患者采用甘精胰岛素和预混胰岛素治疗的效果。方法选择该院2012年1月—2013年12月患者86例,分为两组,各43例,在所有患者同时口服阿卡波糖的基础上,A组每晚10时注射甘精胰岛素1次,而B组每日早晚餐前分别注射预混胰岛素。观察血糖水平、Hb A1c水平、生活质量改善情况。结果 A组胰岛素用量为(13.6±4.7)U/d,明显少于B组(31.3±6.2)U/d(P<0.05)。A组治疗后空腹血糖、餐后2 h血糖、血糖≥10.0 mmol/L曲线下面积所占百分比、糖化血红蛋白水平均明显低于B组(P<0.05)。A组低血糖发生率(6.98%)明显低于B组(37.21%)(P<0.05)。A组SF-36评分高于B组(P<0.05)。结论甘精胰岛素联合阿卡波糖对治疗老年糖尿病患者低血糖具有显著疗效,能显著改善患者生活质量。 Objective To investigate Effectiveness of Insulin glargine and premixed insulin combined with acarbose in improving glycemic levels and life quality of old patients with diadetes. Methods 86 diadetes patients in our hospital from Jan 2012 to Dec2013 were divided into 2 groups, A group were injected with the glargine hypodermically once at 10 O'clock every night and B group were injected with the mixed insulin hypodermically before the meal of morning and evening respectively, all patients were given oral acarbose at the same time.The glycemic levels and life quality between the 2 groups were compared. Results the doses of insulin in A group(13.6±4.7U/d)were lower than in B group(31.3±6.2U/d)(P〈0.05). The FBG, 2h PG, Hb A1 c, AUCPG≥10.0mmol / L% in A group were lower than that in B group(P〈0.05). Scores of eight dimensions of 36-item short-form health survey(SF-36)in observation group were higher than those in control group(P〈0.05. Conclusion Insulin glargine join to acarbose treating old patients with diabetes have ideal effects in controlling glycemic levels with lower risk of hypoglycemia, and can improve the patients' life quality.
出处 《糖尿病新世界》 2015年第1期20-21,共2页 Diabetes New World Magazine
关键词 糖尿病 甘精胰岛素 预混胰岛素 阿卡波糖 生活质量 Diabetes Insulin glargine Premixed insulin Acrabose Life quality
  • 相关文献

参考文献5

二级参考文献37

  • 1张腊梅,李玲.2型糖尿病3种不同胰岛素治疗方法的比较[J].苏州大学学报(医学版),2005,25(6):1104-1105. 被引量:3
  • 2李光伟,宁光,周智广.2型糖尿病早期胰岛素强化治疗改善胰岛β细胞功能——是现实还是梦想?[J].中华内分泌代谢杂志,2006,22(4):309-312. 被引量:223
  • 3穆攀伟,张国超,翁滔华,许海霞,王曼曼,孙卫平,傅静奕,江柏泉,穆曼娜,陈燕铭,曾龙驿.住院糖尿病患者使用甘精胰岛素和NPH控制血糖达标的最小成本分析[J].中华内分泌代谢杂志,2006,22(4):315-318. 被引量:40
  • 4Fumary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting [J]. J Thorac Cardiovasc Surg, 2003,125(5): 1007-1021.
  • 5Li JY, Sun S, Wu SJ. Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery [J]. Tex Heart lnst J, 2006,33 (4): 445-51.
  • 6Goykhman S, Drincic A, Desmangles JC, et al. Insulin Glargine: a review 8 years after its introduction [J]. Expert Opin Pharmacother, 2009, 10(4): 705-18.
  • 7Chatterjee S, Tringham JR, Davies MJ.Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus[J]. Expert Opin Pharmacother, 2006,7( 10): 1357-71.
  • 8Kang H, Ahn K J, Choi JY, et al. Efficacy of insulin glargine in perioperative glucose control in type 2 diabetic patients[J]. Eur J Anaesthesiol, 2009, 26(8): 666-70.
  • 9杨文英.预混胰岛素治疗血糖控制不佳的2型糖尿病患者转换使用甘精胰岛素联合口服药治疗后血糖达标的人群特征分析[J].湘雅论坛壁报,2010,4.
  • 10limepiride Combined with Morning Insulin Glargine,Bedtime Neutral Protamine Hagedorn Insulin,or Bedtime Insulin Glargine in Patients with Type 2 Diabetes.A randomized,controlled trial.Ann Intern Med,2003; 138..952-959.

共引文献68

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部